Search or choose
Find the right test or package.
The Ph-Like ALL Panel is a genetic test used in the diagnosis of Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL). It employs a panel of genetic markers, including rearrangements in genes like ABL1, JAK2, and CRLF2, to identify high-risk...
The Ph-Like ALL Panel is a genetic test used in the diagnosis of Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL). It employs a panel of genetic markers, including rearrangements in genes like ABL1, JAK2, and CRLF2, to identify...
The Ph-Like ALL Panel is a genetic test used in the diagnosis of Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL). It employs a panel of genetic markers, including rearrangements in genes like ABL1, JAK2, and CRLF2, to identify high-risk subtypes of ALL. This testing method helps in classifying patients, predicting outcomes, and guiding treatment strategies. Ph-like ALL panels enable personalized care by identifying specific genetic abnormalities associated with this subtype of leukemia.
The Ph-Like ALL Panel is a genetic test used in the diagnosis of Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL). It employs a panel of genetic markers, including rearrangements in genes like ABL1, JAK2, and CRLF2, to identify high-risk subtypes of ALL. This testing method helps in classifying patients, predicting outcomes, and guiding treatment strategies. Ph-like ALL panels enable personalized care by identifying specific genetic abnormalities associated with this subtype of leukemia.
Find the right test or package.
Pick a convenient time.
A trained expert arrives home.
Samples move through the lab process.
Reports are delivered online.